Boston Scientific Corp. wants to get deeper under your skin. Lawrence C. Best, its chief financial officer, says the company will make more than \$2 billion worth of deals over the next two years, many of them in technologies that play a much more invasive medical role, compared to Boston Scientific's traditional products.